An In Vivo Model for Studying Platelet Aggregation and Disaggregation

Summary

A simple minimally invasive technique has been developed for the continuous monitoring of 111-Indium labelled homologous platelets in the thoracic (C1) and abdominal (C2) regions of experimental animals. The effects of the aggregatory agents adenosine diphosphate (ADP), collagen and platelet activating factor (PAF) and the anti-aggregatory agent, prostacyclin (PGI2) have been studied in the guinea-pig. Administration of ADP, collagen or PAF produces an increase in counts in C1, a decrease in counts in C2, and hence an increase in the ratio C1/C2. The rise in C1/C2 is more protracted after collagen administration than after ADP or PAF. PGI2 (50-500 ng/kg) reduces the response to ADP. The present technique is both simple, reproducible and although the present experiments are in the presence of heparin, the technique remains functional in the presence of minimal heparin, thus making it a suitable method for studies of platelet function and the evaluation of anti-aggregatory agents in vivo.

Key words

Platelets - In vivo aggregation - 111-Indium

• References

• 1 Born GV R. Quantitative investigations into the aggregation of blood platelets. J Physiol 1962; 162: 67-68
• 2 Didisheim P, Fuster V. Actions and clinical status of platelet suppressive agents. Sem Hematol 1978; 15: 55-72
• 3 Smith GM. A study of intravascular platelet aggregation by continuous platelet counting. Trends Pharmacol Sci 1981; 2: 105-107
• 4 Gryglewski RJ, Korbut R, Ocetkiewicz A, Splawinski J, Wojtaszek B, Sweis J. Lungs as a generator of prostacyclin-Hypothesis on physiological significance. Naunyn Schmiedebergs Arch Pharmacol 1978; 304: 45-50
• 5 Honour AJ, Mitchell JRA. Platelet clumping in vivo. Nature 1963; 197: 1019-1020
• 6 Baumgartner HR, Muggli R, Tschopp TB, Turritto VT. Platelet adhesion, release and aggregation in flowing blood: Effects of surface properties and platelet function. Thromb Haemostas 1976; 35: 124-138
• 7 Hawker RJ, Hawker LM. A microtoxicity assay using 111-indium oxine release from platelets. J Immunol Methods 1980; 33: 45-53
• 8 Gaarder A, Jonsen J, Laland S, Hellem AJ, Owren PA. Adenosine diphosphate in red cells as a factor in the adhesivness of human blood platelets. Nature 1961; 192: 531-532
• 9 Chignard M, LeCouedic JP, Tence M, Vargaftig BB, Benveniste J. The role of platelet-activating factor in platelet aggregation. Nature 1979; 279: 799-800
• 10 Hovig T. Aggregation of rabbit blood platelets produced in vitro by saline extract of tendons. Thrombos Diathes Haemorrh 1963; 9: 248-263
• 11 Born GVR, Cross MJ. Effect of adenosine diphosphate on the concentration of platelets in circulating blood. Nature 1963; 197: 974-976
• 12 McManus LM, Hanahan DJ, Demopoulos CA, Pinckard RN. Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF) in the rabbit. J Immunol 1980; 124: 2919-2924
• 13 Bushfield D, Tomich EG. Inhibition by adenosine diphosphate of the thrombocytopenia induced in rabbits by collagen or thrombin. Nature 1968; 217: 376-378
• 14 Davies OJ, Morley J, Page C, Paul W. In vivo aggregation of guinea-pig platelets. J Physiol 1981; 320: 3-4
• 15 Butler KD, Pay GF, Roberts JM, White AM. The effect of sulphinpyrazone and other drugs on the platelet response during the acute phase of the active arthus reaction in guinea pigs. Thromb Res 1979; 15: 319-340
• 16 Lewis JC, O’Flaherty JT, McCall CM, Wykle RL. Endothelial alterations during the platelet activating factor (PAF) respiratory distress syndrome. Thromb Haemostas 1981; 46: 293 (Abstr)
• 17 Constantine JW. Aggregation of guinea-pig platelets by adenosine diphosphate. Nature 1966; 210: 162-164
• 18 MacMillan DC. Secondary clumping effect in human citrated platelet rich plasma produced by adenosine diphosphate and adrenaline. Nature 1966; 211: 140-144
• 19 Vargaftig BB, Lefort J, Joseph D, Fouque F. Mechanisms of bronchoconstriction and of thrombocytopenia induced by collagen in the guinea-pig. Eut J Pharmacol 1979; 58: 273-284
• 20 Chignard M, LeCouedic JP, Vargaftig BB, Benveniste J. Platelet-activating factor (PAF-acether) secretion from platelets: Effect of aggregating agents. Br J Haematol 1980; 46: 455-464
• 21 Vargaftig BB. Platelets and Inflammation. In: Inflammation: Mechanisms and their impact on therapy (Proceedings of an advanced teaching course held in Rotterdam, November 1976). Bonta IL, Thompson J, Brune K. Eds. Birkhauser Verlag, Basel and Stuttgart: 1977: 75-92
• 22 Bunting S, Gryglewski R, Moncada S, Vane JR. Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregation. Prostaglandins 1976; 12: 897-973
• 23 Vargaftig BB, Lefort J, Chignard M, Benveniste J. Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives. Eur J Pharmacol 1980; 65: 185-192
• 24 Page CP, Paul W. An In Vivo aggregometer?. In: Proceedings of the N.A.T.O. Advanced Study Institute on Prostacylin and the Leuko-trienes, Erice, September 1981. Folco GC, Velo GP. Eds. Plenum Press; New York: (In press)